A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices

Results From the MultiSENSE Study

John Boehmer, Ramesh Hariharan, Fausto G. Devecchi, Andrew L. Smith, Giulio Molon, Alessandro Capucci, Qi An, Viktoria Averina, Craig M. Stolen, Pramodsingh H. Thakur, Julie A. Thompson, Ramesh Wariar, Yi Zhang, Jagmeet P. Singh

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objectives The aim of this study was to develop and validate a device-based diagnostic algorithm to predict heart failure (HF) events. Background HF involves costly hospitalizations with adverse impact on patient outcomes. The authors hypothesized that an algorithm combining a diverse set of implanted device-based sensors chosen to target HF pathophysiology could detect worsening HF. Methods The MultiSENSE (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients) study enrolled patients with investigational chronic ambulatory data collection via implanted cardiac resynchronization therapy defibrillators. HF events (HFEs), defined as HF admissions or unscheduled visits with intravenous treatment, were independently adjudicated. The development cohort of patients was used to construct a composite index and alert algorithm (HeartLogic) combining heart sounds, respiration, thoracic impedance, heart rate, and activity; the test cohort was sequestered for independent validation. The 2 coprimary endpoints were sensitivity to detect HFE >40% and unexplained alert rate <2 alerts per patient-year. Results Overall, 900 patients (development cohort, n = 500; test cohort, n = 400) were followed for up to 1 year. Coprimary endpoints were evaluated using 320 patient-years of follow-up data and 50 HFEs in the test cohort (72% men; mean age 66.8 ± 10.3 years; New York Heart Association functional class at enrollment: 69% in class II, 25% in class III; mean left ventricular ejection fraction 30.0 ± 11.4%). Both endpoints were significantly exceeded, with sensitivity of 70% (95% confidence interval [CI]: 55.4% to 82.1%) and an unexplained alert rate of 1.47 per patient-year (95% CI: 1.32 to 1.65). The median lead time before HFE was 34.0 days (interquartile range: 19.0 to 66.3 days). Conclusions The HeartLogic multisensor index and alert algorithm provides a sensitive and timely predictor of impending HF decompensation. (Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices [MultiSENSE]; NCT01128166)

Original languageEnglish (US)
Pages (from-to)216-225
Number of pages10
JournalJACC: Heart Failure
Volume5
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Heart Failure
Equipment and Supplies
Confidence Intervals
Heart Sounds
Cardiac Resynchronization Therapy
Defibrillators
Electric Impedance
Stroke Volume
Respiration
Hospitalization
Thorax
Heart Rate

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Boehmer, John ; Hariharan, Ramesh ; Devecchi, Fausto G. ; Smith, Andrew L. ; Molon, Giulio ; Capucci, Alessandro ; An, Qi ; Averina, Viktoria ; Stolen, Craig M. ; Thakur, Pramodsingh H. ; Thompson, Julie A. ; Wariar, Ramesh ; Zhang, Yi ; Singh, Jagmeet P. / A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices : Results From the MultiSENSE Study. In: JACC: Heart Failure. 2017 ; Vol. 5, No. 3. pp. 216-225.
@article{b9c0ea4ca36f4fd6b452e808173582a1,
title = "A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study",
abstract = "Objectives The aim of this study was to develop and validate a device-based diagnostic algorithm to predict heart failure (HF) events. Background HF involves costly hospitalizations with adverse impact on patient outcomes. The authors hypothesized that an algorithm combining a diverse set of implanted device-based sensors chosen to target HF pathophysiology could detect worsening HF. Methods The MultiSENSE (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients) study enrolled patients with investigational chronic ambulatory data collection via implanted cardiac resynchronization therapy defibrillators. HF events (HFEs), defined as HF admissions or unscheduled visits with intravenous treatment, were independently adjudicated. The development cohort of patients was used to construct a composite index and alert algorithm (HeartLogic) combining heart sounds, respiration, thoracic impedance, heart rate, and activity; the test cohort was sequestered for independent validation. The 2 coprimary endpoints were sensitivity to detect HFE >40{\%} and unexplained alert rate <2 alerts per patient-year. Results Overall, 900 patients (development cohort, n = 500; test cohort, n = 400) were followed for up to 1 year. Coprimary endpoints were evaluated using 320 patient-years of follow-up data and 50 HFEs in the test cohort (72{\%} men; mean age 66.8 ± 10.3 years; New York Heart Association functional class at enrollment: 69{\%} in class II, 25{\%} in class III; mean left ventricular ejection fraction 30.0 ± 11.4{\%}). Both endpoints were significantly exceeded, with sensitivity of 70{\%} (95{\%} confidence interval [CI]: 55.4{\%} to 82.1{\%}) and an unexplained alert rate of 1.47 per patient-year (95{\%} CI: 1.32 to 1.65). The median lead time before HFE was 34.0 days (interquartile range: 19.0 to 66.3 days). Conclusions The HeartLogic multisensor index and alert algorithm provides a sensitive and timely predictor of impending HF decompensation. (Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices [MultiSENSE]; NCT01128166)",
author = "John Boehmer and Ramesh Hariharan and Devecchi, {Fausto G.} and Smith, {Andrew L.} and Giulio Molon and Alessandro Capucci and Qi An and Viktoria Averina and Stolen, {Craig M.} and Thakur, {Pramodsingh H.} and Thompson, {Julie A.} and Ramesh Wariar and Yi Zhang and Singh, {Jagmeet P.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.jchf.2016.12.011",
language = "English (US)",
volume = "5",
pages = "216--225",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier BV",
number = "3",

}

Boehmer, J, Hariharan, R, Devecchi, FG, Smith, AL, Molon, G, Capucci, A, An, Q, Averina, V, Stolen, CM, Thakur, PH, Thompson, JA, Wariar, R, Zhang, Y & Singh, JP 2017, 'A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study', JACC: Heart Failure, vol. 5, no. 3, pp. 216-225. https://doi.org/10.1016/j.jchf.2016.12.011

A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices : Results From the MultiSENSE Study. / Boehmer, John; Hariharan, Ramesh; Devecchi, Fausto G.; Smith, Andrew L.; Molon, Giulio; Capucci, Alessandro; An, Qi; Averina, Viktoria; Stolen, Craig M.; Thakur, Pramodsingh H.; Thompson, Julie A.; Wariar, Ramesh; Zhang, Yi; Singh, Jagmeet P.

In: JACC: Heart Failure, Vol. 5, No. 3, 01.03.2017, p. 216-225.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices

T2 - Results From the MultiSENSE Study

AU - Boehmer, John

AU - Hariharan, Ramesh

AU - Devecchi, Fausto G.

AU - Smith, Andrew L.

AU - Molon, Giulio

AU - Capucci, Alessandro

AU - An, Qi

AU - Averina, Viktoria

AU - Stolen, Craig M.

AU - Thakur, Pramodsingh H.

AU - Thompson, Julie A.

AU - Wariar, Ramesh

AU - Zhang, Yi

AU - Singh, Jagmeet P.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Objectives The aim of this study was to develop and validate a device-based diagnostic algorithm to predict heart failure (HF) events. Background HF involves costly hospitalizations with adverse impact on patient outcomes. The authors hypothesized that an algorithm combining a diverse set of implanted device-based sensors chosen to target HF pathophysiology could detect worsening HF. Methods The MultiSENSE (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients) study enrolled patients with investigational chronic ambulatory data collection via implanted cardiac resynchronization therapy defibrillators. HF events (HFEs), defined as HF admissions or unscheduled visits with intravenous treatment, were independently adjudicated. The development cohort of patients was used to construct a composite index and alert algorithm (HeartLogic) combining heart sounds, respiration, thoracic impedance, heart rate, and activity; the test cohort was sequestered for independent validation. The 2 coprimary endpoints were sensitivity to detect HFE >40% and unexplained alert rate <2 alerts per patient-year. Results Overall, 900 patients (development cohort, n = 500; test cohort, n = 400) were followed for up to 1 year. Coprimary endpoints were evaluated using 320 patient-years of follow-up data and 50 HFEs in the test cohort (72% men; mean age 66.8 ± 10.3 years; New York Heart Association functional class at enrollment: 69% in class II, 25% in class III; mean left ventricular ejection fraction 30.0 ± 11.4%). Both endpoints were significantly exceeded, with sensitivity of 70% (95% confidence interval [CI]: 55.4% to 82.1%) and an unexplained alert rate of 1.47 per patient-year (95% CI: 1.32 to 1.65). The median lead time before HFE was 34.0 days (interquartile range: 19.0 to 66.3 days). Conclusions The HeartLogic multisensor index and alert algorithm provides a sensitive and timely predictor of impending HF decompensation. (Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices [MultiSENSE]; NCT01128166)

AB - Objectives The aim of this study was to develop and validate a device-based diagnostic algorithm to predict heart failure (HF) events. Background HF involves costly hospitalizations with adverse impact on patient outcomes. The authors hypothesized that an algorithm combining a diverse set of implanted device-based sensors chosen to target HF pathophysiology could detect worsening HF. Methods The MultiSENSE (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients) study enrolled patients with investigational chronic ambulatory data collection via implanted cardiac resynchronization therapy defibrillators. HF events (HFEs), defined as HF admissions or unscheduled visits with intravenous treatment, were independently adjudicated. The development cohort of patients was used to construct a composite index and alert algorithm (HeartLogic) combining heart sounds, respiration, thoracic impedance, heart rate, and activity; the test cohort was sequestered for independent validation. The 2 coprimary endpoints were sensitivity to detect HFE >40% and unexplained alert rate <2 alerts per patient-year. Results Overall, 900 patients (development cohort, n = 500; test cohort, n = 400) were followed for up to 1 year. Coprimary endpoints were evaluated using 320 patient-years of follow-up data and 50 HFEs in the test cohort (72% men; mean age 66.8 ± 10.3 years; New York Heart Association functional class at enrollment: 69% in class II, 25% in class III; mean left ventricular ejection fraction 30.0 ± 11.4%). Both endpoints were significantly exceeded, with sensitivity of 70% (95% confidence interval [CI]: 55.4% to 82.1%) and an unexplained alert rate of 1.47 per patient-year (95% CI: 1.32 to 1.65). The median lead time before HFE was 34.0 days (interquartile range: 19.0 to 66.3 days). Conclusions The HeartLogic multisensor index and alert algorithm provides a sensitive and timely predictor of impending HF decompensation. (Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices [MultiSENSE]; NCT01128166)

UR - http://www.scopus.com/inward/record.url?scp=85014123006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014123006&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2016.12.011

DO - 10.1016/j.jchf.2016.12.011

M3 - Article

VL - 5

SP - 216

EP - 225

JO - JACC: Heart Failure

JF - JACC: Heart Failure

SN - 2213-1779

IS - 3

ER -